Huntington's disease affects GABAergic function in cortico-subcortical pathways.
TMS was used to study whether sex modulates pathophysiology in Huntington's disease.
Cortical inhibition was significantly reduced in symptomatic Huntington's disease.
Females exhibited significantly reduced cortical inhibition compared with males.
Sex differences do not interact with inhibitory deficits in Huntington's disease.